Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 1.56 +0.03 (1.96%)
Previous Close $1.53    52 Week High $16.39 
Open $1.54    52 Week Low $13.22 
Day High $1.56    P/E N/A 
Day Low $1.52    EPS $-1.61 
Volume 20,622       

EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) Delayed: 28.23 +0.24 (0.86%)
Previous Close $27.99    52 Week High $21.25 
Open $28.11    52 Week Low $16.37 
Day High $28.31    P/E N/A 
Day Low $27.97    EPS $0.00 
Volume 103,861       

(NASDAQ: NAGE) Delayed: 3.05 +0.04 (1.33%)
Previous Close $3.01    52 Week High $ 
Open $3.02    52 Week Low $ 
Day High $3.06    P/E N/A 
Day Low $2.98    EPS $ 
Volume 618,996